Global Communications Manager, Eli Lilly

My name's Jen Dial, I'm a global communications manager at Eli Lilly and Company. I work with a lot of different individuals internally any time that we're getting ready to do something external, so any time, I work with media daily and strategically work on our communication front. Whether that's putting together our communication plans, whether it's our press releases, our data milestones, so different phases of research we have to announce at a certain time, and with that announcement I work with our legal, I'll work with our investor relations I work with our different medical folks and kind of piecing together everything that we need to be talking about externally. Different data milestones, different communication campaigns that we have, FDA approvals, and work closely with our marketing peers and everything and our social media as well. There's a lot of different components that work into it. Basically, you know, one of the roles that I'm in is that there are millions of patients out there who have an unmet need and there isn't something currently on the market that is helping them with their pain or helping them with their certain disease state and part of my area is that I help with that communication side and bring that out and to the media. Bring it out to the different stakeholders, whether that's different physician groups, whether it's investors, whether it's, you know, the general media, if it's trade media, business media, consumer media. There's a lot of different avenues to go through. But, by bringing that information out there potentially to patients or potentially to physicians to help them understand what the options are for patients or help bring additional education around specific disease state is essential. I primarily work with media. With media, I mean anything that is an earned media. It's not a paid-for advertisement like you would see in advertising or marketing, this is more of an earned media space. I'm working with different reporters, whether it's from trade, whether it's all the way up to top tier, whether that you're talking about Washington Post, CNN, ABC, that kind of thing to different business outlets as well, talking about the certain messagings that we're wanting to get out there, whether it's for our investor community, whether it's for the physician community, whether it's for consumers, to understand whether it's the disease state or our latest data that we released on a certain area, whether it's for migraine or a different product that we're working on leading up to hopeful FDA approval. And then thereafter, to help educate that special audience that we're trying to go after and understanding what we're trying to communicate to them.